• Biomimetic Chromatography for Modeling Pulmonary Drug Permea

  2026-05-27

  This study systematically compares biomimetic open tubular capillary electrochromatography and immobilised artificial membrane chromatography, both coupled with mass spectrometry, for modeling lung permeability of pharmaceuticals. The findings establish robust, high-throughput workflows for predicting pulmonary absorption, with direct implications for respiratory drug development and asthma inflammation models.

• Inhibition of Kir2.1 Reduces PASMC Proliferation in PH Model

  2026-05-27

  The referenced study demonstrates that Kir2.1 potassium channels play a pivotal role in regulating pulmonary artery smooth muscle cell (PASMC) proliferation and migration, which are crucial processes in pulmonary vascular remodeling associated with pulmonary hypertension (PH). Targeted inhibition of Kir2.1, using a selective inhibitor, attenuated these pathogenic cellular behaviors by modulating the TGF-β1/SMAD2/3 pathway, highlighting Kir2.1 as a promising research target for cardiovascular ion channel studies.

• DCPS Identified as m7G Biomarker in Diabetic Foot Ulcers

  2026-05-26

  The reference study uncovers the decapping scavenger enzyme (DCPS) as a novel N7-methylguanosine (m7G)-related biomarker that regulates epithelial cell function during diabetic foot ulcer (DFU) healing. By integrating transcriptomic analysis and functional assays, the researchers demonstrate that DCPS downregulation impairs cell cycle progression, proliferation, and migration in keratinocytes, offering new insights for DFU diagnostics and therapeutic targeting.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Translational Immunotherapy

  2026-05-26

  Explore how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) is redefining immunotherapy research by enabling precise, stable cytokine expression with advanced mRNA modifications. This article uniquely dissects extrahepatic mRNA delivery strategies and provides actionable insights for translational applications.

• Precision Apoptosis Detection: Advanced Insights with the On

  2026-05-25

  Explore the One-step TUNEL Cy5 Apoptosis Detection Kit for high-precision apoptosis detection in tissue and cell models. This article delivers a deep scientific analysis, practical protocol guidance, and unique insights into integrating TUNEL assays with current research on drug resistance and cancer epigenetics.

• ABT-737: Advancing BCL-2 Inhibition for Translational Oncolo

  2026-05-25

  Explore the mechanistic, strategic, and translational landscape of ABT-737—a potent BCL-2 protein inhibitor—through the lens of apoptosis induction, immune evasion, and clinical relevance. This thought-leadership article bridges deep biological insights with actionable guidance for researchers aiming to translate BCL-2 targeting into next-generation cancer therapies.

• Trifluoperazine 2HCl: Advanced Workflows for Dopaminergic an

  2026-05-24

  Trifluoperazine 2HCl empowers researchers to dissect dopamine D2 receptor signaling and leverage host-directed strategies against intracellular pathogens. This guide integrates leading-edge protocols and troubleshooting tips to maximize reproducibility in neuropharmacology, immunology, and translational models.

• EdU Flow Cytometry Assay Kits (Cy5): Practical Workflow Guid

  2026-05-23

  The EdU Flow Cytometry Assay Kits (Cy5) address the need for non-denaturing, high-sensitivity quantification of S-phase DNA synthesis by leveraging click chemistry. Recommended for researchers requiring precise cell proliferation analysis in flow cytometry, the kit is not suited for fixed-tissue or in situ imaging workflows.

• Indole-3-pyruvic Acid Feedback Regulation in Auxin Biosynthe

  2026-05-22

  This study reveals a pivotal feedback mechanism in plant auxin biosynthesis, demonstrating that indole-3-pyruvic acid (IPA) directly inhibits TAA1 activity to coordinate the two enzymatic steps that produce indole-3-acetic acid (IAA). These findings clarify a core aspect of plant hormone regulation, with implications for auxin-related developmental research and metabolic engineering.

• Applied Workflows with 5-Aminolevulinic acid HCl in Heme Bio

  2026-05-22

  5-Aminolevulinic acid HCl empowers precision in heme biosynthesis research, bridging host-pathogen interaction studies with translational oncology. This guide details experimental setup, protocol optimizations, and troubleshooting tips, leveraging APExBIO’s high-purity reagent for reproducible, cutting-edge results.

• Scenario-Driven Solutions for Apoptosis Research Using Boc-D

  2026-05-21

  This article addresses key laboratory challenges in apoptosis and inflammation studies, demonstrating how Boc-D-FMK (SKU A1904) from APExBIO provides reproducible, robust solutions. Through scenario-based Q&A, researchers gain practical insights, protocol parameters, and evidence-based guidance for optimizing cell viability and cytotoxicity assays.

• Acifran in Lipid Metabolism: Mechanistic Insight & Translati

  2026-05-21

  Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid) is redefining lipid metabolism research as a selective agonist for HM74A/GPR109A and GPR109B receptors. This thought-leadership article synthesizes recent cryo-EM structural breakthroughs, delivers practical experimental guidance, and analyzes the translational potential of Acifran as a hypolipidemic agent—positioning it as a critical tool for dissecting lipid signaling pathways and advancing metabolic disorder research.

• EdU Flow Cytometry Assay Kits (Cy3) for Robust Cell Cycle An

  2026-05-20

  Unlock precise, denaturation-free S-phase detection with EdU Flow Cytometry Assay Kits (Cy3), enabling multiplexed cell proliferation studies and streamlined genotoxicity testing. APExBIO’s optimized CuAAC workflow delivers superior sensitivity and workflow efficiency, transforming experimental reproducibility in cancer and pharmacodynamic research.

• QPRT Drives Breast Cancer Invasion via P2Y11 and Myosin Path

  2026-05-20

  Liu et al. reveal that quinolinate phosphoribosyltransferase (QPRT) promotes breast cancer invasiveness by enhancing myosin light chain phosphorylation through purinergic P2Y11 receptor signaling. Pharmacological inhibition, including the use of a selective P2Y11 antagonist, reverses these effects, offering mechanistic insight into NAD+ metabolism’s role in tumor progression and potential intervention points.

• YM-155 hydrochloride: Precision Survivin Inhibitor Workflows

  2026-05-19

  YM-155 hydrochloride enables highly selective targeting of survivin, empowering robust apoptosis inhibitor research in diverse cancer models. This guide delivers advanced experimental workflows, protocol parameters, and actionable troubleshooting strategies to unlock its full potential.

16134 records 1/1076 page Next 12345 下5页 Last page